Tandem Diabetes Care, Inc.
NasdaqGM:TNDM
$ 35.56
+ $0.44 (1.25%)
$ 35.56
+ $0.44 (1.25%)
End-of-day quote: 04/25/2024

Tandem Diabetes Care financials at a glance

The revenue of Tandem Diabetes Care is reported as 0.74772 billion Dollars in the fiscal year 2023. The earnings were -1.57 Dollars per share in 2023, which was 112.16 lower than 2022. And about -0.00202 billion Dollars are reported as free cash flow in the financials of Tandem Diabetes Care 2023. No dividends were paid to the shareholders of the Tandem Diabetes Care stock NasdaqGM:TNDM in the financial year 2023.

$747.72M
Revenue
$-1.57
Earnings Per Share
49.17%
Gross Margin %
$-47.19M
Free Cash Flow
Revenue
747.72
Earnings Per Share
-1.57
Gross Margin %
49.17
Free Cash Flow
-47.19

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Rev. Revenue N/A $747.72M $801.22M $702.80M $498.83M $362.31M $183.87M $107.60M $84.25M $72.85M $49.72M $29.01M
GM % Gross Margin % 50.55% 49.17% 51.54% 53.53% 52.23% 53.60% 48.85% 40.98% 28.00% 36.49% 30.67% 21.26%
OM Operating Margin -17.54% -20.66% -7.48% 3.22% -1.60% -4.62% -24.27% -58.50% -92.64% -94.72% -,152.17% -,170.42%
EPS Earnings Per Share $-3.22 $-1.57 $-0.74 $0.24 $-0.56 $-0.42 $-2.55 $-13.41 $-27.30 $-25.00 $-34.20 $-,214.60
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 -0.00% -0.00% 0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0 -0.00%
Sha. Shares N/AM 65.63M 64.53M 63.87M 62.5M 59.73M 57.72M 44.7M 3.13M 3.03M 2.37M 2.29M
OCF Operating Cash Flow N/A $24.78M $100.61M $111.36M $24.67M $41.91M $-8.32M $-66.14M $-61.17M $-58.76M $-61.38M $-47.76M
FCF Free Cash Flow N/A $-47.19M $62.99M $97.18M $-2.74M $22.36M $-11.31M $-71.85M $-70.10M $-64.52M $-65.78M $-51.77M
FCFS Free Cash Flow Per Share $-0.75 $-1.28 $0.12 $1.39 $-0.13 $0.38 $-0.23 $-12.66 $-22.93 $-22.34 $-28.34 $-,182.76